concenterbiopharma.com | Concenter BioPharma

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.concenterbiopharma.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Concenter BioPharma \| Focused on People &
Description	Concenter BioPharma Developing Novel, First in Class Drugs, Treating and Preventing Type 2 Diabetes, Based on a
Keywords	N/A

Server Information

WebSite	concenterbiopharma.com
Host IP	185.230.63.171
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

concenterbiopharma.com Valuation

US$868

Last updated: 2023-05-20 07:04:53

concenterbiopharma.com has Semrush global rank of 0. concenterbiopharma.com has an estimated worth of US$ 868, based on its estimated Ads revenue. concenterbiopharma.com receives approximately 100 unique visitors each day. Its web server is located in -, with IP address 185.230.63.171. According to SiteAdvisor, concenterbiopharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$868
Daily Ads Revenue	US$0
Monthly Ads Revenue	US$24
Yearly Ads Revenue	US$288
Daily Unique Visitors	6
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
concenterbiopharma.com.	A	3599	IP: 185.230.63.171
concenterbiopharma.com.	A	3599	IP: 185.230.63.107
concenterbiopharma.com.	A	3599	IP: 185.230.63.186
concenterbiopharma.com.	NS	86400	NS Record: ns15.wixdns.net.
concenterbiopharma.com.	NS	86400	NS Record: ns14.wixdns.net.
concenterbiopharma.com.	MX	3600	MX Record: 50 aspmx3.googlemail.com.
concenterbiopharma.com.	MX	3600	MX Record: 40 aspmx2.googlemail.com.
concenterbiopharma.com.	MX	3600	MX Record: 20 alt1.aspmx.l.google.com.
concenterbiopharma.com.	MX	3600	MX Record: 30 alt2.aspmx.l.google.com.
concenterbiopharma.com.	MX	3600	MX Record: 10 aspmx.l.google.com.
concenterbiopharma.com.	TXT	86400	TXT Record: google-site-verification=0D4jhvVjFYjkSJZcosWhEa8WZjiCe4EuwJUiODV6mxQ

HtmlToTextCheckTime:2023-05-20 07:04:53

top of page Subscribe to Stay Tuned Emails Concenter Bio Pharma Concenter BioPharma About Strategy Events & News Leadership Contact Developing Novel, First in Class Drugs, Treating and Preventing Type 2 Diabetes, Based on a Core-Technology-Platform. תודה לכל האנג’לים שהשקיעו בגיוס יולי 2022! הצטרפו היום כבעלי מניות בקונסנטר ביופארמה < לחצו כאן לפרטים נוספים על קמפיין גיוס ההמונים Link to the Campaign Website> FOCUSED ON PEOPLE & THERAPIES Short Summary Pipeline IND in process Type 2 Diabetes Drug Professor Chevion and co-inventors developed a family of non-steroidal chemical complexes, made of components approved for clinical use. These New Chemical Entities constitute a protected PLATFORM of DRUGS, with proven efficacy and complete safety, for treatments of multiple indications. Concenter BioPharma is developing and commercializing the drug which treats and prevents Type 2 Diabetes. The drug has 3 synergistic Mechanisms of Action, extensively tested in animal models of human

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Fri, 20 Jan 2023 09:27:56 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.concenterbiopharma.com/
strict-transport-security: max-age=3600
Age: 82153
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=84
X-Seen-By: RQvnDyN5n1orR2cJk2hJbg==,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgS+Hj2MokSER7h+mpPdHRZ,m0j2EEknGIVUW/liY8BLLugxpzo4Lzk5UB/xu5OzG7jJftmKrOReD3ukbbas4YDo,2d58ifebGbosy5xc+FRalsLRQv6ye8rfSu0ddg93JcyW8gCKy3RmesnDCzOviDWpcsEvvv72nQWabWjhUD32zQ==,2UNV7KOq4oGjA5+PKsX47AgwiXskEY9NBGhMxjF/VCG8ZDY613cHYLbuhNMgAom1
Cache-Control: no-cache
X-Wix-Request-Id: 1674206876.055363599825822894
X-Content-Type-Options: nosniff

HTTP/2 200 
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"199c13655efb6bd33ea0a7be13ec8a46"
content-language: en
strict-transport-security: max-age=3600
x-wix-request-id: 1674206876.249479066452149192
cache-control: public,max-age=0,must-revalidate
x-content-type-options: nosniff
server: Pepyaka/1.19.10
accept-ranges: bytes
date: Fri, 20 Jan 2023 09:27:56 GMT
age: 143283
x-served-by: cache-hhn-etou8220088-HHN
x-cache: MISS
vary: Accept-Encoding
server-timing: cache;desc=hit, varnish;desc=hit_miss, dc;desc=fastly_g
set-cookie: ssr-caching=cache#desc=hit#varnish=hit_miss#dc#desc=fastly_g; max-age=20
x-seen-by: yvSunuo/8ld62ehjr5B7kA==,6ivkWfREES4Y8b2pOpzk7Owfbs+7qUVAqsIx00yI78k=,GXNXSWFXisshliUcwO20NU53gQymTA7BCiXxfWA0+Jc4p8QF20SMVG1OJ2firsem,m0j2EEknGIVUW/liY8BLLvRKfhx2uNN4hv3eFGgKFZEa0sM5c8dDUFHeNaFq0qDu,2d58ifebGbosy5xc+FRaliO17kxj0KnzzIX6nBc7kpB9jSGFGoPIxoHsn5m9eg+sgtHzVmRkUGUVWxavW6HJ0A==,2UNV7KOq4oGjA5+PKsX47DbjvEddsBhwcQg3CC6woG5YgeUJqUXtid+86vZww+nL
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

concenterbiopharma.com valuation and analysis